ArticleBrain and behavior2022

Targeting microglial NLRP3 in the SNc region as a promising disease-modifying therapy for Parkinson's disease.

Chen Qiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.